Related Experiment Videos

[Electrophysiological evaluation of retrograde cardioplegia--experimental study of efficacy for the right ventricle]

H Utsunomiya1, M Ikeshita, T Shoji

  • 1Department of Thoracic and Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|October 1, 1990
PubMed

Insights

Retrograde coronary sinus cardioplegia with diltiazem offers superior right ventricular protection during coronary artery bypass grafting compared to standard antegrade methods. This technique ensures better myocardial preservation, especially in challenging multi-vessel obstruction cases.

Area of Science:

  • Cardiovascular Surgery
  • Myocardial Protection
  • Electrophysiology

Context:

  • Increasing coronary artery bypass grafting (CABG) for multi-vessel coronary obstructions.
  • Limitations of antegrade cardioplegia in delivering solution beyond proximal blockages.
  • Retrograde coronary sinus cardioplegia as a potential alternative.

Purpose:

  • To evaluate the efficacy of retrograde coronary sinus cardioplegia for right ventricular protection.
  • To compare retrograde cardioplegia (with and without diltiazem) against antegrade cardioplegia.
  • To assess myocardial preservation using electrophysiological and ultrastructural methods.

Summary:

  • Thirty-six dogs received retrograde cardioplegia (GIK or GIK+diltiazem) or antegrade cardioplegia (GIK).
  • Retrograde cardioplegia with diltiazem (Group II) showed significantly better preservation of right ventricular electrical activity and ultrastructure compared to GIK alone (Group I) and antegrade cardioplegia (Group III).
  • Unipolar peak-to-peak amplitude (UPPA) analysis indicated superior myocardial preservation in Group II.

Impact:

  • Retrograde coronary sinus cardioplegia, particularly when combined with diltiazem, presents a promising strategy for enhanced right ventricular protection in CABG.
  • This technique may improve outcomes for patients with complex coronary artery disease where antegrade delivery is compromised.
  • Further clinical investigation is warranted to validate these findings in human subjects.

Related Concept Videos